Researchers at Sant Pau Research Institute, in partnership with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed a groundbreaking CAR-T cell therapy—HSP-CAR30—targeting the CD30 protein. This therapy has shown promising results in a Phase I clinical

During World Immunisation Week, the World Health Organisation (WHO) renewed its commitment to safeguarding children from vaccine-preventable diseases, stressing the transformative power of vaccines in improving health, education, and national development. In a video message, Saima Wazed, WHO South-East Asia